The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the α‐fetoprotein status
Martin Volkmann, Martina Müller, Walter J. Hofmann, Martina Meyer, Jens Hagelstein, Ulrich Räth, Burkhard Kommerell, Hanswalter Zentgraf, Peter R. Galle – 1 September 1993 – Recently, p53 gene aberrations have been recognized as a relevant factor in hepatocarcinogenesis, in tumors from both high‐risk and low‐risk areas. Because p53 gene mutations typically result in increased p53 levels in tumor cells, this cellular protein might become immunogenic during tumor development.